Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Canellos

Showing results (21-30 of 23) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 23 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1993
A randomized clinical trial comparing melphalan/prednisone with or without interferon alfa-2b in newly diagnosed patients with multiple myeloma: a Cancer and Leukemia Group B studyM R Cooper, K Dear, O R McIntyre, et al.
Cancer|April 15, 1993
Prognostic factors for patients with Hodgkin disease in first relapseE A Healey, N J Tarbell, L A Kalish, et al.
Leukemia & Lymphoma|July 24, 2009
Recombinant interferon-alpha2b added to oral cyclophosphamide either as induction or maintenance in treatment-naive follicular lymphoma: final analysis of CALGB 8691S M Smith, J Johnson, B D Cheson, et al.
Pageof 3

Showing results (21-30 of 23) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 23 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1993
A randomized clinical trial comparing melphalan/prednisone with or without interferon alfa-2b in newly diagnosed patients with multiple myeloma: a Cancer and Leukemia Group B studyM R Cooper, K Dear, O R McIntyre, et al.
Cancer|April 15, 1993
Prognostic factors for patients with Hodgkin disease in first relapseE A Healey, N J Tarbell, L A Kalish, et al.
Leukemia & Lymphoma|July 24, 2009
Recombinant interferon-alpha2b added to oral cyclophosphamide either as induction or maintenance in treatment-naive follicular lymphoma: final analysis of CALGB 8691S M Smith, J Johnson, B D Cheson, et al.
Pageof 3